A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
The clinical course of 130 patients with Burkitt's lymphoma was reviewed. Death occurred soon after treatment in 18 (14%), and failure to respond to chemotherapy was observed in 5 (4%). One hundred seven patients achieved complete remissions, among whom 84 were followed for at least 1 year, or until relapse. Tumor relapse was observed to be of two distinct types. Early relapse was characterized by recurrent tumor growth in the same site as the original tumor and occurred within 10 weeks ofpmid:5030826 fatcat:xth7pkdckbgqbbslaujjh6j3xa